<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:34:13" record="17318" source="Espacenet">
	<entities>
		<entity ref="Patent17318" type="Patent">
			<semanticIdentifier>brcris::5e382a9913791a577b76b342b7b1a572</semanticIdentifier>
			<semanticIdentifier>docdb::BR102016004295A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102016004295</semanticIdentifier>
			<semanticIdentifier>docdb::BR102016004295A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20161004295</semanticIdentifier>
			<semanticIdentifier>original::102016004295</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102016004295"/>
			<field name="identifier.lattes" value="4136088050114641"/>
			<field name="identifier.espacenet" value="102016004295"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="composição farmacêutica de medicamento à base de própolis"/>
			<field name="title.lattes" value="COMPOSIÇÃO FARMACÊUTICA DE MEDICAMENTO À BASE DE PRÓPOLIS"/>
			<field name="depositDate" value="2016-02-25"/>
			<field name="publicationDate" value="2018-04-03"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="GERALDO BATISTA DE MELO"/>
			<field name="inventor" value="KARINNE SPIRANDELLI CARVALHO NAVES"/>
			<field name="inventor" value="MARCIA LUCIA APARECIDA ESTEVAO"/>
			<field name="inventor" value="MICHEL RODRIGUES MOREIRA"/>
			<field name="inventor" value="SONIA APARECIDA VASCONCELOS ORTU"/>
			<field name="applicant" value="KIROPHARMA FARMACIA LTDA"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE UBERLANDIA"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K47/08AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="08AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K35/644AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="644AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K47/10AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="10AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61K47/38AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="38AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P33/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="abstract.espacenet" value="composição farmacêutica de medicamento à base de própolis a presente invenção consiste de uma composição farmacêutica em forma de gel reabsorvivel contendo própolis para uso tópico em infecções por herpes simples vírus (hsv) tipos i, ii, iii, hpv e adenovírus. com o objetivo da terapia antiviral, esta composição visa impedir a adsorção viral à célula susceptível e bloquear a replicação viral, abreviando o período sintomático e acelerar a resolução de lesões. atualmente é observado um aumento da resistência em muitos vírus, aos antivirais, notado pela não resposta esperada ao tratamento chegando, em alguns pacientes, ao uso de medicação quase que constante por apresentarem recorrências frequentes destas viroses. desta forma, temos observado que a terapia com nossa formulação farmacêutica pode contribuir para reduzir as recidivas, o tempo de evolução e o desconforto dos pacientes."/>
			<field name="originatesFrom" value="62062577"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102016004295"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102016004295"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102016004295"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20161004295"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102016004295"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person11995" type="Person">
			<semanticIdentifier>lattes::4136088050114641</semanticIdentifier>
			<field name="identifier.lattes" value="4136088050114641"/>
			<field name="name" value="Geraldo Batista de Melo"/>
		</entity>
		<entity ref="OrgUnit9407" type="OrgUnit">
			<semanticIdentifier>brcris::fa95793bd10cf2105122ea0e931c861a</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE UBERLANDIA"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent17318" toEntityRef="Person11995" type="Inventor"/>
		<relation fromEntityRef="Patent17318" toEntityRef="OrgUnit9407" type="Applicant"/>
	</relations>
</entity-relation-data>
